1. Home
  2. PRTA vs CECO Comparison

PRTA vs CECO Comparison

Compare PRTA & CECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • CECO
  • Stock Information
  • Founded
  • PRTA 2012
  • CECO 1966
  • Country
  • PRTA Ireland
  • CECO United States
  • Employees
  • PRTA N/A
  • CECO N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • CECO Pollution Control Equipment
  • Sector
  • PRTA Health Care
  • CECO Industrials
  • Exchange
  • PRTA Nasdaq
  • CECO Nasdaq
  • Market Cap
  • PRTA 809.8M
  • CECO 867.1M
  • IPO Year
  • PRTA N/A
  • CECO N/A
  • Fundamental
  • Price
  • PRTA $15.27
  • CECO $24.24
  • Analyst Decision
  • PRTA Buy
  • CECO Strong Buy
  • Analyst Count
  • PRTA 9
  • CECO 5
  • Target Price
  • PRTA $54.57
  • CECO $36.50
  • AVG Volume (30 Days)
  • PRTA 396.4K
  • CECO 268.6K
  • Earning Date
  • PRTA 05-07-2025
  • CECO 04-29-2025
  • Dividend Yield
  • PRTA N/A
  • CECO N/A
  • EPS Growth
  • PRTA N/A
  • CECO N/A
  • EPS
  • PRTA N/A
  • CECO 0.36
  • Revenue
  • PRTA $135,157,000.00
  • CECO $557,933,000.00
  • Revenue This Year
  • PRTA N/A
  • CECO $27.25
  • Revenue Next Year
  • PRTA $106.71
  • CECO $9.34
  • P/E Ratio
  • PRTA N/A
  • CECO $67.33
  • Revenue Growth
  • PRTA 47.92
  • CECO 2.40
  • 52 Week Low
  • PRTA $11.70
  • CECO $20.00
  • 52 Week High
  • PRTA $30.86
  • CECO $35.16
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 54.26
  • CECO 38.95
  • Support Level
  • PRTA $13.89
  • CECO $23.22
  • Resistance Level
  • PRTA $16.16
  • CECO $24.83
  • Average True Range (ATR)
  • PRTA 1.14
  • CECO 1.12
  • MACD
  • PRTA 0.04
  • CECO 0.18
  • Stochastic Oscillator
  • PRTA 53.11
  • CECO 47.14

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

Share on Social Networks: